Based on this assessment, no known safety concerns or ingredient interactions with GLP-1 medications were identified
Patients who qualify for Noom's microdosing program get the medication plus psychological support to adopt healthier habits, Egler notes.
Bottom Line: Personally, I was excited by the wide-ranging positive signals for GLP-1 drugs uncovered by this discovery analysis
Among currently available agents, GLP-1 RAs - and tirzepatide in particular, based on the SURMOUNT-1 subgroup analysis - have the most substantial weight-loss evidence in this population, with efficacy appearing comparable to that observed in common obesity
Contrave A combination of bupropion and naltrexone, Contrave could be an especially good choice for people with depression, ADHD, emotional eating or significant cravings, as it supports appetite suppression